P3 Health Partners (PIII) Stock: Buy, Sell, or Hold?
PIII - P3 Health Partners Inc. Common Stock
$6.27
-0.50 (-7.32%)
▼
5d:
-11.06%
30d:
-29.47%
90d:
-44.85%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Get Alerted When PIII Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PIII is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PIII is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PIII is currently trading at $6.27, which is considered oversold relative to its 30-day fair value range of $7.14 to $9.36.
Technical Outlook: Technically, PIII is in a downtrend. The price is currently testing key support at $6.23. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: PIII scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+187.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PIII is in a downtrend. The price is currently testing key support at $6.23. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: PIII scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.00 (+187.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.14 -
$9.36
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 187.1% below Wall St target ($18.00)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.14 -
$9.36
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.23
Resistance Level
$8.14
Current Trend
Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.45
Wall Street Target
$18.00
(+187.1%)
Revenue Growth (YoY)
8.6%
Profit Margin
-6.6%
Share & Embed Analysis
Last updated: October 02, 2026 6:41 AM ET
Data refreshes hourly during market hours. Next update: 7:41 AM
Data refreshes hourly during market hours. Next update: 7:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PIII showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 58 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 46 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 45 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 53 HOLD |
